← BioNTech SE

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $61.6m
$127.6m +107.11%
$108.6m -14.88%
$482.3m +344.17%
$19.0b +3834.42%
$17.3b -8.78%
$3.8b -77.94%
$2.8b -27.96%
$2.9b +4.32%
$2.6b -7.66%
Revenue From Interest — $2.0m $1.8m $1.6m $1.5m $48.5m $357.6m $437.6m — —
Cost of Goods and Services Sold ($9.3m)
$13.7m +246.92%
$17.4m +26.82%
$59.3m +241.76%
$2.9b +4807.05%
$3.0b +2.87%
$599.8m -79.97%
$541.3m -9.75%
$641.8m +18.57%
$650.0m +1.28%
Cost of sales ($9.3m)
($13.7m) -46.92%
($17.4m) -26.82%
($59.3m) -241.76%
($2.9b) -4807.05%
($3.0b) -2.87%
($599.8m) +79.97%
($541.3m) +9.75%
($641.8m) -18.57%
$650.0m +201.28%
Cost Of Revenue ($9.3m)
$13.7m +246.92%
$17.4m +26.82%
$59.3m +241.76%
$2.9b +4807.05%
$3.0b +2.87%
$599.8m -79.97%
$541.3m -9.75%
$641.8m +18.57%
$650.0m +1.28%
Net Interest Income — — — — — ($18.9m)
($7.5m) +60.32%
($17.2m) -129.33%
($12.6m) +26.74%
($28.7m) -127.78%
Gross Profit $52.3m
$113.9m +117.84%
$91.2m -19.89%
$423.0m +363.66%
$16.1b +3697.99%
$14.3b -10.89%
$3.2b -77.51%
$2.2b -31.36%
$2.2b +0.83%
$2.0b -10.24%
Research and development $85.5m $143.0m $226.5m $645.0m $949.2m $1.5b $1.8b $2.3b $2.1b $2.2b
Sales and marketing expenses ($6.6m) ($3.0m) ($2.7m) ($14.5m) ($50.4m) ($59.5m) ($62.7m) ($67.9m) ($110.0m) —
Selling And Marketing Expense — — — — — $59.5m $62.7m $67.9m $110.0m $788.8m
General and administrative $23.5m $26.3m $45.5m $94.0m $285.8m $484.7m $495.0m $531.1m $514.4m $644.2m
General And Administrative Expense — — — — — $481.7m $524.4m $644.8m $588.2m $644.2m
Restructuring And Mergern Acquisition — — — — ($2.2m) — $0 $0 ($15.0m) $0
Operating expenses:
Other operating expenses ($288k) ($720k) ($739k) ($2.4m) ($94.4m) ($407.0m) ($293.0m) ($811.5m) ($1.1b) —
Other Operating Income Expense $2.3m $4.7m $2.0m $250.5m $598.4m $815.3m $105.0m ($670.9m) ($903.7m) —
Interest Expense — — — — — $18.9m $7.5m $16.9m $14.2m $14.3m
Interest Expense On Lease Liabilities — $1.7m $1.7m $2.0m $2.9m $5.1m $5.7m $8.6m $8.2m $14.3m
Interest Income — $2.0m $1.8m $1.6m $1.5m $48.5m $357.6m $437.6m — $437.7m
Net Non Operating Interest Income Expense — — — — — ($18.9m) ($7.5m) ($17.2m) ($12.6m) ($28.7m)
Gain On Sale Of Security — — — — — $672.2m $318.8m $710.5m $383.4m $389.7m
Other Income — — — — — — — — $103.1m —
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method — ($84k) — — — — — — — —
Other Expenses — — — — — — $7.9m — — —
Other Income Expense — — — — — $669.2m $318.0m $48.9m ($397.5m) ($370.8m)
Pre-Tax Income ($85.9m) ($47.7m) ($179.4m) ($145.8m) $15.0b $13.0b $1.2b ($677.7m) ($1.1b) ($1.6b)
Income taxes ($45k) ($600k) $268k $161.0m ($4.8b) ($3.5b) ($255.8m) $12.4m ($85.3m) —
Current Tax Expense (Income) — — — $17k $4.5b $3.6b $243.1m ($2.3m) $11.4m —
Deferred Tax Expense (Income) — — — ($161.0m) $218.9m ($109.9m) $12.7m ($10.1m) $73.9m —
Net Income From Continuing And Discontinued Operation ($85.7m) ($48.0m) ($179.1m) $15.2m $10.3b $9.4b $930.3m ($665.3m) ($1.1b) ($1.7b)
Basic Earnings (Loss) Per Share — — ($0.85) $0.06 $42.18 $38.78 $3.87 ($2.77) ($4.70) ($6.71)
Diluted Earnings (Loss) Per Share ($0.51) ($0.25) ($0.85) $0.06 $39.63 $37.77 $3.83 ($2.77) ($4.70) ($6.71)
Basic Average Shares — — — — — $243.3m $240.6m $240.2m $241.7m $247.9m
Diluted Average Shares — — — — — $249.8m $242.7m $240.2m $241.7m $247.9m
Additional Financial Items
Applicable Tax Rate — $0 $0 $0 $0 $0 $0 $0 — —
Average Effective Tax Rate — — — — $0 $0 $0 $0 ($0) —
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss — — — — — — — — $57.2m —
Depreciation Right of Use Assets — $2.8m $4.7m $6.3m $29.0m $58.8m $45.2m $45.6m $42.7m —
Finance Income $2.1m $8.0m $4.1m $1.6m $67.7m $330.3m $519.6m $664.0m $423.9m —
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss — — — — — — — — $500k —
Profit Loss Attributable To Noncontrolling Interests — ($243k) ($116k) — $0 — — — — —
Profit Loss Attributable To Owners Of Parent ($85.7m) ($48.0m) ($179.1m) $15.2m $10.3b $9.4b $930.3m ($665.3m) ($1.1b) —
Profit Loss Before Tax ($85.9m) ($47.7m) ($179.4m) ($145.8m) $15.0b $13.0b $1.2b ($677.7m) ($1.1b) —
Profit Loss From Operating Activities ($61.3m) ($53.9m) ($181.5m) ($82.4m) $15.3b $12.6b $690.4m ($1.3b) ($1.4b) —
Operating profit / (loss) ($61.3m)
($53.9m) +12.11%
($181.5m) -237.06%
($82.4m) +54.60%
$15.3b +18644.48%
$12.6b -17.28%
$690.4m -94.54%
($1.3b) -290.37%
($1.4b) -6.89%
—
Net profit / (loss) ($86.0m) ($48.3m) ($179.2m) $15.2m $10.3b $9.4b $930.3m ($665.3m) ($1.1b) —
Profit attributable to ordinary equity holders of the parent for basic earnings ($85.7m) ($48.0m) ($179.1m) $15.2m $10.3b $9.4b $930.3m ($665.3m) ($1.1b) —
Non-controlling interests ($297k) ($243k) ($116k) $0 $0 — — — — —
Diluted EPS ($0.51) ($0.25) ($0.85) $0.06 $39.63 $37.77 $3.83 ($2.77) ($4.70) ($6.71)
Diluted NI Availto Com Stockholders ($85.7m) ($48.0m) ($179.1m) $15.2m $10.3b $9.4b $930.3m ($665.3m) ($1.1b) ($1.7b)
Insurance And Claims — — — — $30.4m $21.3m — — — —
Normalized EBITDA — — — — — $12.4b $1.1b ($411.7m) ($256.3m) ($938.8m)
Normalized Income — — — — — $8.9b $681.0m ($713.3m) ($822.1m) ($1.5b)
Other Gand A — — — — — $481.7m $524.4m $644.8m $588.2m —
Other Special Charges — — — — — $3.0m $29.4m $657.4m $789.5m —
Reconciled Depreciation — — — — — $123.3m $183.4m $298.0m $382.8m $676.4m
Salaries And Wages — — — — $90.5m $153.7m — — — —
Selling General And Administration — — — — — $541.2m $587.1m $712.7m $698.2m —
Special Income Charges — — — — — ($3.0m) ($800k) ($661.6m) ($780.9m) ($760.5m)
Tax Effect Of Unusual Items — — — — — $182.0m $68.7m $880k ($83.5m) ($148.3m)
Tax Provision — — — — — $3.5b $255.8m ($12.4m) $85.3m $56.9m
Tax Rate For Calcs — — — — — $0 $0 $0 $0 $0
Write Off — — — — — — $800k $4.2m $6.4m $200k
Employee Benefits Expense — — — $179.4m $378.8m $605.5m $698.6m $931.2m $1.0b —
Expense From Share-Based Payment Transactions With Employees — — — — $93.7m $108.0m $51.4m $100.9m $106.3m —
Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used — $90k $90k $300k $400k — — — — —
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — $431k $442k $875k $9.1m — — — — —
Finance Costs — $48k $326k $62.9m $305.1m $18.9m $23.9m $27.4m $69.8m —
Other Employee Expense — — — — — — — — $57.0m —
Other Finance Cost — — — — — — — $12.6m $7.2m —
Postemployment Benefit Expense Defined Benefit Plans — — — $761k $1.2m $2.1m $4.1m $3.5m $4.7m —
Finance expenses ($26.0m) ($48k) ($326k) ($62.9m) ($305.1m) ($18.9m) ($23.9m) ($27.4m) ($69.8m) —
Operating Expense — — — — — $2.0b $2.3b $2.9b $2.9b $3.2b
Net Foreign Exchange Loss — — — $42.6m $0 $0 $16.0m $0 $48.4m —
Total Unusual Items — — — — — $669.2m $318.0m $48.9m ($397.5m) ($370.8m)
Total Expenses — — — — — $5.0b $2.9b $3.5b $3.5b $3.2b
Total Other Finance Cost — — — — — $2.7m $7.9m $300k ($1.6m) ($3.4m)

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.